F13.27
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia
Clinical Classification Guidelines
Inclusion Terms
- Sedative, hypnotic, or anxiolytic use disorder, moderate, with sedative, hypnotic, or anxiolytic-induced major neurocognitive disorder
- Sedative, hypnotic, or anxiolytic use disorder, severe, with sedative, hypnotic, or anxiolytic-induced major neurocognitive disorder
Medical Intelligence & Overview
ICD-10 code F13.27 describes a complex condition where a person develops dependence on sedative, hypnotic, or anxiolytic medications and then also experiences a type of cognitive decline known as persisting dementia caused by these same substances. This condition reflects both substance use disorder and ongoing neurocognitive impairment, which can significantly impact daily functioning and quality of life. Recognizing and understanding this diagnosis is essential for providing appropriate care and support.
Causes & Symptoms
Clinical Causes: Prolonged use or high doses of sedative, hypnotic, or anxiolytic medications, such as benzodiazepines or sleep aids. Chronic use leading to physical and psychological dependence on these medications. Genetic factors that may predispose individuals to substance dependence. Underlying mental health conditions, like anxiety or sleep disorders, which often lead to the sustained use of these medications. Inadequate monitoring or unsupervised use of prescribed medications that can lead to misuse and dependency.
Key Symptoms: Persistent memory problems and difficulty concentrating. Confusion or disorientation that does not resolve. Impaired reasoning and other cognitive deficits characteristic of dementia. Signs of dependence such as cravings, withdrawal symptoms, or unsuccessful attempts to stop medications. Behavioral changes including agitation, irritability, or withdrawal from social activities. Sleep disturbances that may persist despite medication use. Possible physical symptoms include tremors, sweating, or nausea upon withdrawal or reduction of medication.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical assessment by a healthcare professional, including a detailed review of medication history, cognitive testing, and evaluation for signs of dependence. Neuropsychological evaluations can help confirm the presence of dementia-related changes. Medical history, medication review, and possibly laboratory tests are used to rule out other causes of cognitive decline and substance dependence. The diagnosis aligns with criteria for both substance use disorder and major neurocognitive disorder caused by sedative, hypnotic, or anxiolytic agents.
Treatment Protocols: Gradual tapering of the offending medications under medical supervision to reduce withdrawal risks. Cognitive rehabilitation and therapies aimed at improving or stabilizing cognitive function. Psychosocial support and counseling to address underlying mental health conditions. Use of alternative therapies for sleep or anxiety, such as non-pharmacologic methods or safer medication options. Monitoring for and managing withdrawal symptoms or other adverse effects. Long-term management and support to prevent relapse into dependency and to cope with cognitive challenges.
Clinical Advice & FAQs
Billing Guidance
Is F13.27 a billable ICD-10 code?
Yes, F13.27 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.27?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference